NK cell dysfunction, marked by diminished activating receptor signaling and sustained HLA-I expression on tumor cells, further reinforces immune escape mechanisms—likely via engagement of HLA-I-specific inhibitory receptors such as KIRs and NKG2A [86]. Here, KLRC1 is linked to neoplasm.